Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 6,000 shares at $19.87 ($119K) on 2026-05-29, disclosed to the SEC on 2026-06-01.
Scheduled sale ($119k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GLUE | SELL | 2026-06-18 | $57K | — | Filing → |
| GLUE | SELL | 2026-01-05 | $48K | — | Filing → |